[go: up one dir, main page]

ZA896202B - Production of bluetongue virus non-structural proteins using a baculovirus expression vector - Google Patents

Production of bluetongue virus non-structural proteins using a baculovirus expression vector

Info

Publication number
ZA896202B
ZA896202B ZA896202A ZA896202A ZA896202B ZA 896202 B ZA896202 B ZA 896202B ZA 896202 A ZA896202 A ZA 896202A ZA 896202 A ZA896202 A ZA 896202A ZA 896202 B ZA896202 B ZA 896202B
Authority
ZA
South Africa
Prior art keywords
production
expression vector
structural proteins
baculovirus expression
bluetongue virus
Prior art date
Application number
ZA896202A
Inventor
Polly Dr Roy
Roy Dr Polly
Original Assignee
Roy Dr Polly
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roy Dr Polly filed Critical Roy Dr Polly
Publication of ZA896202B publication Critical patent/ZA896202B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ZA896202A 1988-08-16 1989-08-15 Production of bluetongue virus non-structural proteins using a baculovirus expression vector ZA896202B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888819453A GB8819453D0 (en) 1988-08-16 1988-08-16 Production of bluetongue virus non-structural proteins using baculovirus expression vector

Publications (1)

Publication Number Publication Date
ZA896202B true ZA896202B (en) 1990-08-29

Family

ID=10642209

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA896202A ZA896202B (en) 1988-08-16 1989-08-15 Production of bluetongue virus non-structural proteins using a baculovirus expression vector

Country Status (5)

Country Link
EP (1) EP0431038A1 (en)
AU (1) AU4198889A (en)
GB (1) GB8819453D0 (en)
WO (1) WO1990002186A1 (en)
ZA (1) ZA896202B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1324770A2 (en) * 2000-09-27 2003-07-09 The UAB Research Foundation Non-replicative particulate vaccine delivery system and methods of making and using same
NZ586034A (en) 2004-02-02 2011-10-28 Ambrx Inc Modified human growth hormone polypeptides and their uses
JP2008503217A (en) 2004-06-18 2008-02-07 アンブレツクス・インコーポレイテツド Novel antigen-binding polypeptides and their use
MX2007000728A (en) 2004-07-21 2007-03-15 Ambrx Inc Biosynthetic polypeptides utilizing non-naturally encoded amino acids.
SG161209A1 (en) 2004-12-22 2010-05-27 Ambrx Inc Formulations of human growth hormone comprising a non-naturally encoded amino acid
US8080391B2 (en) 2004-12-22 2011-12-20 Ambrx, Inc. Process of producing non-naturally encoded amino acid containing high conjugated to a water soluble polymer
US7736872B2 (en) 2004-12-22 2010-06-15 Ambrx, Inc. Compositions of aminoacyl-TRNA synthetase and uses thereof
GB2438982A (en) 2004-12-22 2007-12-12 Ambrx Inc Compostions containing, methods involving, and uses of non-natural amino acids and polypeptides
JP2008525473A (en) 2004-12-22 2008-07-17 アンブレツクス・インコーポレイテツド Modified human growth hormone
JP2008541769A (en) 2005-06-03 2008-11-27 アンブレツクス・インコーポレイテツド Improved human interferon molecules and their use
CA2618878C (en) 2005-08-18 2016-06-28 Ambrx, Inc. Compositions of trna and uses thereof
AU2006315347A1 (en) 2005-11-16 2007-05-24 Ambrx, Inc. Methods and compositions comprising non-natural amino acids
SG174788A1 (en) 2006-09-08 2011-10-28 Ambrx Inc Suppressor trna transcription in vertebrate cells
EP2069396B1 (en) 2006-09-08 2015-10-21 Ambrx, Inc. Modified human plasma polypeptide or fc scaffolds and their uses
MX2009002460A (en) 2006-09-08 2009-03-20 Ambrx Inc Hybrid suppressor trna for vertebrate cells.
HRP20120522T1 (en) 2007-03-30 2012-08-31 Ambrx Modified fgf-21 polypeptides and their uses
KR20100019467A (en) 2007-05-02 2010-02-18 암브룩스, 인코포레이티드 Modified interferon beta polypeptides and their uses
JP5547083B2 (en) 2007-11-20 2014-07-09 アンブルックス，インコーポレイテッド Modified insulin polypeptides and their use
SG188143A1 (en) 2008-02-08 2013-03-28 Ambrx Inc Modified leptin polypeptides and their uses
EP3225248B1 (en) 2008-07-23 2023-06-07 Ambrx, Inc. Modified bovine g-csf polypeptides and their uses
CN102224238B (en) 2008-09-26 2015-06-10 Ambrx公司 Non-natural amino acid replication-dependent microorganisms and vaccines
ES2631915T3 (en) 2008-09-26 2017-09-06 Ambrx, Inc. Modified polypeptides of animal erythropoietin and its uses
EP2516455A4 (en) 2009-12-21 2013-05-22 Ambrx Inc MODIFIED PORCINE GROWTH HORMONE POLYPEPTIDES AND USES THEREOF
EP2516454A4 (en) 2009-12-21 2013-05-22 Ambrx Inc Modified bovine somatotropin polypeptides and their uses
PT2605789T (en) 2010-08-17 2019-09-03 Ambrx Inc Modified relaxin polypeptides and their uses
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
AR083006A1 (en) 2010-09-23 2013-01-23 Lilly Co Eli FORMULATIONS FOR THE STIMULATING FACTOR OF COLONIES OF GRANULOCITS (G-CSF) BOVINE AND VARIANTS OF THE SAME
EP3209316A2 (en) 2014-10-24 2017-08-30 Bristol-Myers Squibb Company Modified fgf-21 polypeptides and uses thereof
BR112019016139A2 (en) 2017-02-08 2020-04-07 Bristol-Myers Squibb Company modified relaxin polypeptide comprising a pharmacokinetic enhancer and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU591459B2 (en) * 1984-08-31 1989-12-07 Research Corporation cDNA probe for the detection of bluetongue virus
AP114A (en) * 1987-02-19 1991-02-01 Oxford Virology Ltd Production of bluetongue virus antigens using a baculovirus expression vector.

Also Published As

Publication number Publication date
AU4198889A (en) 1990-03-23
EP0431038A1 (en) 1991-06-12
GB8819453D0 (en) 1988-09-21
WO1990002186A1 (en) 1990-03-08

Similar Documents

Publication Publication Date Title
ZA896202B (en) Production of bluetongue virus non-structural proteins using a baculovirus expression vector
PT91631A (en) A PROCESS FOR THE PREPARATION OF CYCLIC GRAF-ANALOGS II
AU3756789A (en) Antagonists of viral transactivating proteins
GB2225322B (en) A process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
ZA891355B (en) Expression of hiv binding proteins
AP8800083A0 (en) Production of bluetongue virus antigens using a baculovirus expression vector
GB8821507D0 (en) Improvements relating to peptides
GB2221904B (en) Production of alkanols
GB2193462B (en) Location of jointed textiles in a mould
IL89601A0 (en) Expression vectors containing a recombinant vaccinia virus
GB9003489D0 (en) A ring resonator gyro
GB8825390D0 (en) Production of chloride-free fertilizers-11
ZA893579B (en) Antigenic polypeptides of taenia ovis
ZA88849B (en) Production of bluetongue virus antigens using a baculovirus expression vector
IE883483L (en) Expression of hiv proteins
EP0323846A3 (en) Process of preparing thiamphenicol
AU100881S (en) A set of foldable suspension tiles
ZA893263B (en) Production of polypeptides
IE881482L (en) Recombinant htlv-iii proteins
ZA894489B (en) Preparation of a demethyltetralin
IE894106L (en) Expression of the plasmodium circumsporozite protein in¹insects
AU104945S (en) A segment of a craypot upper
IE881635L (en) Human immunodeficiency virus gag-encoded proteins
AU104687S (en) A set of dolls
GB8813746D0 (en) Peptide fragments of hiv